Technical Analysis for MREO - Mereo BioPharma Group plc

Grade Last Price % Change Price Change
grade B 4.1 3.54% 0.14
MREO closed up 3.54 percent on Wednesday, August 21, 2019, on 1.35 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Up Up
See historical MREO trend table...

Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Upper Bollinger Band Walk Strength 0.00%
Wide Bands Range Expansion 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Up 5 Days in a Row Strength 0.00%
New Uptrend Bullish 3.54%

Older signals for MREO ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Mereo is a biopharmaceutical company focused on the development and commercialization of innovative therapeutics that aim to improve outcomes for patients with rare diseases. Mereo's strategy is to selectively acquire product candidates that have substantial preclinical, clinical and manufacturing data packages. Mereo's four product candidates have previously generated positive clinical data for Mereo's target indications or in related indications. Mereo has commenced randomized Phase 2 clinical trials for all four of the product candidates. In connection with the merger with OncoMed, Mereo added two candidates to its pipeline, Navicixizumab and Etigilimab.
Health Biopharmaceutical Pharmaceutical Industry Drug Discovery Clinical Trial Rare Diseases Design Of Experiments Clinical Research Compugen
Is MREO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 8.48
52 Week Low 2.18
Average Volume 28,903
200-Day Moving Average 0.0
50-Day Moving Average 2.7911
20-Day Moving Average 2.9732
10-Day Moving Average 3.272
Average True Range 0.3123
ADX 27.54
+DI 39.8184
-DI 11.7459
Chandelier Exit (Long, 3 ATRs ) 3.3321
Chandelier Exit (Short, 3 ATRs ) 3.2069
Upper Bollinger Band 3.8857
Lower Bollinger Band 2.0607
Percent B (%b) 1.12
BandWidth 61.381676
MACD Line 0.2692
MACD Signal Line 0.1074
MACD Histogram 0.1619
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.50
Resistance 3 (R3) 4.52 4.39 4.44
Resistance 2 (R2) 4.39 4.29 4.39 4.41
Resistance 1 (R1) 4.25 4.23 4.18 4.23 4.39
Pivot Point 4.12 4.12 4.09 4.12 4.12
Support 1 (S1) 3.98 4.02 3.92 3.97 3.81
Support 2 (S2) 3.85 3.96 3.85 3.79
Support 3 (S3) 3.71 3.85 3.76
Support 4 (S4) 3.70